探讨老年急性髓细胞性白血病的有效治疗方案。
To explore of the efficient treating method for acute myeloid leukemia in the elderly.
预激方案；急性髓细胞性白血病；粒细胞集落刺激因子；
Priming induction regimen; Acute myeloid leukemia(AML); Granulocyte colony stimulating factor;
目的：探讨儿童慢性髓细胞性白血病（CML）临床及实验室特征。
Objective Study on the clinical and experimental characters of the chronic myelocytic leukemia(CML)of children.
与急性髓细胞性白血病相比，急性淋巴细胞性白血病细胞免疫功能更为低下。
Compared with acute myelogenous leukemia, patients with acute lymphoblastic leukemia had more poor cellular immune function.
目的了解细胞程序死亡(PCD)与慢性髓细胞性白血病(CML)急变的关系。
Objective To investigate the association of the programmed cell death (PCD) regulating proteins with the acute transformation of chronic myelogenous leukemia (CML).
急性髓细胞性白血病(aml)很难治愈，不过可喜的是近年来疗效已有所改善。
AML is a hard blood cancer to cure. The good news is that there has been improvement in treatment results in recent years.
【译】结合在细胞遗传学正常的急性髓细胞性白血病的分子和复发和生存的预后指标。
Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia.
替匹法尼用一周，停一周剂量递增治疗复发性，难治性或高危髓细胞性白血病1阶段试验。
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia.
该药可以阻断引起慢性髓细胞性白血病（CML）的突变蛋白，成为第一个特异靶向癌细胞的化学药。
The drug blocks a mutant protein that causes chronic myelogenous leukemia (CML), becoming the first chemotherapy to specifically target cancer cells.
结论：DCIK能诱导机体产生特异性的免疫反应，对急性髓细胞性白血病的治疗有较好的临床疗效。
Conclusion: DCIK can induce specific immunoreaction in the immune system and has satisfactory clinical anticancer efficacy in treatment of AML.
目的报道1例以CD7+和双重t（8；21）易位为特征的近四倍体克隆急性髓细胞性白血病（AML）。
Objective To report a case of acute myeloid leukemia (AML) with CD7 + near-tetraploid clones by doublet(8; 21).
干扰素是能够产生多向性生物学效应的细胞因子家族，在毛细胞白血病、慢性髓细胞性白血病治疗中疗效显著。
Interferons, a cytokines family, a re capable of producing multiplex biological effects, and have remarkable curative effects on hair cell leukemia and chronic myelogenous leukemia.
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
而格列卫，来自于慢性髓细胞性白血病的药物。Vogelstein说：“我们的工作提示大多数实体肿瘤实际上不同于CML。”
While Gleevec, a pill, transformed the treatment of a blood cancer called chronic myeloid leukemia, "our work suggests that most solid tumors are really nothing like CML," Vogelstein said.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
目的观察131I-GMCSF诱导HL60/ADM细胞凋亡，探讨其诱导HL60/ADM细胞凋亡的机制，比较131I-GMCSF对HL60/ADM细胞和HL60细胞的细胞毒作用，为其临床治疗难治性或复发性急性髓细胞性白血病提供实验依据。
Objective: To compare the cytotoxicity of HL60/ADM cells and HL60 cells treated with 131I-GMCSF and to investigate the mechanism of the apoptosis of HL-60/ADM cells induced by 131I-GMCSF.
我们进行了一项临床试验旨在分析伏立康唑在急性髓细胞白血病化疗诱导阶段预防肺部浸润的有效性和安全性。
We conducted a trial to analyze the efficacy and safety of voriconazole in the prevention of lung infiltrates during induction chemotherapy for acute myelogenous leukaemia (AML).
目的：髓性白血病患者的白血病细胞体外诱导分化成为树突状细胞。
OBJECTIVE: to induce and differentiate into dendritic cells from leukemic cells of patients with myeloid leukemia.
目的：将慢性髓性白血病患者的白血病细胞体外诱导分化成为树突状细胞。
Objective: to induce and differentiate into dendritic cells from leukemic cells of patients with chronic myeloid leukemia.
比较淋巴细胞性白血病(LL)及髓细胞白血病(ML)脊椎骨髓mri表现的异同。
To compare the manifestations of spinal marrow on MRI in lymphoid leukemia (LL) and myeloid leukemia (ML).
目的研究二烯丙基二硫(DADS)诱导人髓性白血病HL - 60细胞分化过程中蛋白质组的差异表达。
Objective To study differential proteomic expression in the differentiation of HL-60 cells induced by diallyl disulfide (DADS).
目的：观察典型慢性髓系白血病骨髓涂片，探讨用常规血细胞形态学方法分型的可能性。
Objective: Observation of bone marrow smears of typical chronic myeloid leukemia to investigate the Possibility of morphological classification of the disease.
研究方法：用流式细胞仪检测30例急性髓性白血病的P_(170)和活化t细胞的表达。
Methods: Flow cytometer (FCM) was used in detection of the expression of P170 and active t cell in leukemic cells from 30 cases of AML patients.
给华盛顿大学捐赠细胞的该名女性患有急性髓性白血病，这是一种进展非常快的癌症，美国每年有13000人患病，其中8800人死亡。
The woman at Washington University had acute myelogenous leukemia, a fast-growing cancer that affects about 13,000 people a year in the United States and kills 8,800.
MDS是一组异质性很强的疾病，其特征为：血细胞减少、无效造血及进展为急性髓系白血病风险。
MDS is a group of very heterogeneous disorders characterized by cytopenias, inefficient hematopoiesis and the risk of progression into acute myeloid leukemia.
须与类白血病相鉴别，可用的检测是粒细胞碱性磷酸酶(LAP)，慢性髓性白血病较低而类白血病反应较高。
A useful test to help distinguish this disease is the leukocyte alkaline phosphatase (LAP) score, which should be low with CML and high with a leukemoid reaction.
JANEX- 1具有良好的抗白血病活性，它可诱导酪氨酸蛋白激酶过度表达的淋巴性白血病细胞和髓性白血病细胞凋亡。
JANEX-1 exhibits significant anti-leukemia activity, which could induce apoptosis in human lymphoblastic as well as myeloblastic leukemia cells with over-expressed tyrosine protein kinase.
目的：化疗药物对急性髓性白血病细胞体外毒性进行相关性研究。
Objective:To study the correlation between cytotoxicity of daunorubicine (DNR) and harringtonine (H) to leukemic cells in vitro from 39 patients with acute myeloblastic leukemia (AML).
目的：研究昆布多糖硫酸酯（LAMS）对急性髓性白血病HL - 6 0细胞株的调控作用。
Objective:To study the effects of LAMS on modulation of HL-60 cell strain.
目的：研究昆布多糖硫酸酯（LAMS）对急性髓性白血病HL - 6 0细胞株的调控作用。
Objective:To study the effects of LAMS on modulation of HL-60 cell strain.
应用推荐